Arkolith/Insider Trading/ATRA/Form 4

Panacea Innovation Ltd

10% OwnerAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Mar 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2026Option exercise(M)259K—$0308K
Mar 17, 2026Tax withholding(F)5$5.23$26308K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2026Option exercise(M)259K$6.61$1.7M0

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-116060) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML